Live · 27.3k readers this week

Should you actually take it? Real verdicts on the peptides everyone’s Googling.

Hype, hope, or real? Side-by-side: what the internet is claiming, what the evidence backs up, and whether it’s worth your money.

Educational reference. Not medical advice.

SpecimenBPC-157 reference chain
GEPPPGKPADDAGLV
Formula
C62H98N16O22
Mass
1419.53
Evidence
Animal / preclinical
Residues
15

Reality checks

Hot takes, fact-checked.

Browse all
Longevity + Skin4 minAnimal / preclinical

MOTS-c Is on the WADA Banned List. The Human Data Isn't.

USADA this fall classified the mitochondrial exercise-mimetic peptide as prohibited in sport — ahead of any completed randomized controlled trial.

Fat Loss + GLP-1s4 minApproved

Liraglutide Just Went Generic. The Price Is $226 Now. The Receipts Are Interesting.

Generic liraglutide landed in U.S. pharmacies in 2025 — and by September 2026, it costs $226 while semaglutide commands $1,300.

Fitness + Recovery4 minEarly human

RFK Jr. Said Ipamorelin Was Coming Back. His Own FDA Panel Already Said No.

RFK Jr. championed ipamorelin on Joe Rogan in February 2026. His own FDA advisory panel had already voted against it in October 2024.

Fitness + Recovery4 minAnimal / preclinical

BPC-157 Just Won an FDA Panel Vote. Here's the Part That Got Buried.

An FDA panel voted yes on BPC-157 this summer — tied to a gut indication, not the recovery claims driving 73,000 monthly searches.

Fat Loss + GLP-1s4 minApproved

Semaglutide Is a Pill Now. Nine Months of Real-World Switching Data Drops at EASD This Week.

The world's biggest diabetes conference opens Monday in Milan — and Novo Nordisk is presenting the first real-world data on whether patients who switched from injections to the oral Wegovy pill held their results.

Fitness + Recovery4 minEarly human

Thymosin Beta-4 Is Having a Moment. The Clinical Trials Are About Hearts, Not Tendons.

The peptide behind TB-500's recovery marketing is in cardiac trials right now — and recovery is its least-studied application.

Browse all 133 reality checks

Search the index

Find the peptide everyone’s talking about. See if it’s real.

109peptides decoded40FDA-approved93with human data
10 Showing top 10 of 109 — search to see more
Browse all 109 peptides in the Atlas
What people are asking right nowSemaglutideShould you actually try semaglutide for weight loss?TirzepatideTirzepatide vs Ozempic — which one actually works?BPC-157Is BPC-157 the recovery hack — or all hype?

How we cut through the noise

The hype, the science, and where they don’t match.

Browse all

01 / PROFILE

Peptide Profiles

Each entry explains what the peptide is, why people search for it, the proposed mechanism, and where the evidence stops.

BPC-157Animal / preclinicalRecovery claims

02 / NEWS

Reality checks, daily

Clickbait headlines with real receipts. Daily article on a trending peptide — what people are claiming, what the evidence actually shows, where the line is.

TRIALSPUBMEDLABELS

03 / SAFETY

Safety Context

Profiles include risks, unknowns, approval context, and clear boundaries around dosing, sourcing, and personal medical advice.

SAFETY NOTEEducational content only; clinical decisions belong with qualified care.

04 / CATEGORY

Category Index

Compare fitness and recovery, GLP-1 and metabolic, longevity and skin, endogenous biology, and approved clinical peptides.

Compact category topologyN01N02N03N04N05N06N07N08PROFILE MAPEVIDENCE LAYERCATEGORY CLUSTER
Evidence scanner

Every claim gets a label before it gets a headline.

PeptideFactCheck separates approved use, human signal, early research, preclinical biology, anecdotes, and unknowns so curiosity does not become fake certainty.

ApprovedOfficial regulatory approval exists for at least one specific use.
Human-supportedHuman clinical data supports at least some claims, with scope and limits made explicit.
Early humanSmall, preliminary, or narrow human studies exist, but the evidence is not mature.
Animal / preclinicalThe strongest evidence is animal, cell, or mechanism research rather than clinical outcomes.
AnecdotalMost public claims come from user reports, clinics, vendors, forums, or social media.
UnknownReliable source data is too sparse or inconsistent to classify confidently.

Why you can trust the verdicts

We don’t take influencers’ word for it. Here’s who we DO trust.

IUPHAR/BPS, PubChem, UniProt, RCSB PDB, PubMed, Europe PMC, and ClinicalTrials.gov are used for molecular and research context.

FDA Orange Book, DailyMed, openFDA, and FDA safety communications are used for U.S. regulatory and label context.

Vendor pages, forum posts, and clinic claims can explain public interest, but they are not treated as authoritative evidence.

SAFETY NOTEThis content is educational only and does not replace medical advice. Peptide use may carry risks and should be discussed with a qualified medical professional.